Impact of sirolimus on renal transplant outcomes in African Americans.
Podder
H
H
Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas, USA.
Podbielski
J
J
Hussein
I
I
Katz
S M
SM
Van Buren
C T
CT
Kahan
B D
BD
D001741:Black or African American; D015331:Cohort Studies; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005938:Glucocorticoids / Q000008:administration & dosage; D006084:Graft Rejection / Q000208:ethnology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016030:Kidney Transplantation; D011241:Prednisone / Q000008:administration & dosage; D020123:Sirolimus / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone; D020123:Sirolimus